HTLV-II infection in a Liverpool intravenous drug user
β Scribed by C.M. Parry; A.D. Harries; N.J. Beeching; I.M. Shaw; K.J. Mutton; L. McAlpine; J.H.C. Tosswill; P.W. Tuke; J.A. Garson
- Publisher
- Elsevier Science
- Year
- 1991
- Tongue
- English
- Weight
- 209 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0163-4453
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In order to investigate the prevalence of HIV infection among Greek intravenous drug users (IVDU), its trend during years recent and possible risk factors, we studied 893 inmates recently admitted to the main prisons of Greece from 1986 to 1989. Screening and counselling was offered to all of them.
## Abstract The clinical relevance of hepatitis B virus (HBV) genotypes has been documented; however, the prevalence of mixed HBV genotype infections in atβrisk groups remains controversial. The HBV genotypes were determined in 325 HBVβinfected intravenous drug users (IVDU) who were at a greater ri
## Abstract The most highβrisk population for HCV transmission worldwide today are intravenous drug users. HCV genotypes in the general population in Cyprus demonstrate a polyphyletic infection and include subtypes associated with intravenous drug users. The prevalence of HCV, HBV, and HIV infectio
## Abstract Six hundred intravenous drug users (IVDUs) and two hundred North Africans were screened for human Tβcell leukemia virus (HTLV) antibodies using several serological methods. Eighteen of the eightyβtwo HTLVβseropositive individuals were also tested by the polymerase chain reacβ tionβDNA e